The Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. capital markets practice is widely recognised for advising managers on equity transactions in the life sciences and biotech sectors. The group is led by John Rudy in Boston and Daniel Bagliebter in New York. Bagliebter focuses on securities offerings and mergers and acquisitions, with particular strength in IPOs and follow-on public offerings, while Rudy brings extensive experience across equity and debt financings, securities matters and general corporate advisory work. The bench was further strengthened by the arrival of Alok Choksi, who joined the firm from Haynes and Boone, L.L.P. in April 2025.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Sector knowledge
Key clients
- Leerink Partners
- Oppenheimer & Co.
- ArriVent BioPharma, Inc.
- Sera Prognostics
- Elicio Therapeutics
- Wave Life Sciences
- Standard BioTools
- Guggenheim
- TD Cowen
- EcoR1
Work highlights
Represented Galecto, Inc in connection with its acquisition of Damora Therapeutics, Inc, and the concurrent $285 million private placement.
Advised the underwriters in connection with a $603 million public offering by Praxis Precision Medicines.
Advised the underwriters in connection with the $425 million underwritten offering by Ondas Holdings Inc.
Practice head
John Rudy; Daniel Bagliebter
Other key lawyers
Alok Choksi